Relevant pharmacokinetics, bioavailability, and bioequivalence studies on Chlorpheniramine maleate (various species): a review
César Alas-Pineda, Dennis J. Pavón-Varela, Kristhel Gaitán-Zambrano, Gustavo Ferrer · 2025
Read Relevant pharmacokinetics, bioavailability, and bioequivalence studies on Chlorpheniramine maleate (various species): a review by César Alas-Pineda, Dennis J. Pavón-Varela, Kristhel Gaitán-Zambrano, Gustavo Ferrer (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12741130.txt.
Description
César Alas-Pineda, Dennis Pavón-Varela, Kristhel Gaitán-Zambrano, and Gustavo Ferrer published a 2025 review of how the allergy drug chlorpheniramine maleate behaves in the body across species. The drug is a first generation antihistamine used worldwide. Yet how it is absorbed, how much reaches the blood, and how species differ were poorly charted.
The scoping review followed standard guidelines and searched the literature on human and animal studies. Searches covered bioavailability, bioequivalence, and nose delivered forms of the drug. The authors compare findings across species and formulations, with special weight on nasal and cheek routes that bypass the gut. Such routes could act faster and dodge first pass breakdown. The synthesis supports work on new formulations and on translating animal data to people.
Catalog record
| CREATOR | César Alas-Pineda, Dennis J. Pavón-Varela, Kristhel Gaitán-Zambrano, Gustavo Ferrer |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |